newsfilter
← Latest News
PR Newswire·

Seneca Biopharma Granted 180-Day Extension by NASDAQ to Regain Compliance with Bid Price Rule

Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need,...